ARCHIVES

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

This article is from The Cancer Letter archive.

Vol. 15 No. 30 | July 28, 1989

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Scientists May Run For Congress; Upton Back Heroin For Terminal Cancer Patients

September 9, 1977

$2.5 Million NCI Grant To Fund Brachytherapy Improvement

February 27, 2004

In Brief: Chemical Carcinogenesis, Epidemiology Trail Viral Oncology In Budget Growth, Board Notes

November 7, 1980

Reagan’s Freeze Chills NCI Plan To Hire Outsiders

January 30, 1981

Obama Picks Hamburg for FDA Commissioner

March 20, 2009

ImClone “Screwed Up,” CEO Waksal Tells Conference; Stock Plunges.

January 11, 2002